The Office of HIV and AIDS Malignancy (OHAM) coordinates and oversees NCI-sponsored research on AIDS-related cancers and HIV/AIDS. OHAM also acts as a point of contact for the National Institutes of Health (NIH) Office of AIDS Research (OAR).
OHAM has two programs:
The AIDS Malignancy Program, which has primary responsibility for identifying new initiatives; for sponsoring international activities, such as the Strengthening Capacity for Research for HIV-Associated Malignancies in Africa initiative; and for overseeing programs that NCI co-manages with other NIH institutes, such as the Centers for AIDS Research, the Multicenter AIDS Cohort Study, the Women's Interagency HIV Study, and the International Epidemiology Databases to Evaluate AIDS.
The AIDS Cancer Clinical Program, which has primary responsibility for overseeing clinical programs in OHAM, including the AIDS Malignancy Consortium and the AIDS and Cancer Specimen Resource.
The two intramural divisions of NCI, the Center for Cancer Research (CCR) and the Division of Cancer Epidemiology and Genetics (DCEG), conduct research on both HIV and HIV/AIDS-associated cancer. For example, DCEG is conducting the HIV/AIDS Cancer Match Study, which uses data previously collected by public health agencies to examine cancer risk in people with HIV. Nearly all other NCI divisions, offices, and centers also support HIV/AIDS research.